PepGen Inc.
PEPG · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary
5 Item 1A. Risk Factors 32 Item 1B. Unresolved Staff Comments 94 Item 1C. Cybersecurity 94 Item 2. Properties 95 Item 3. Legal Proceedings 95 Item 4. Mine Safety Disclosures 95 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 96 Item 6. [Reserved] 96 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 97 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 105 Item 8...
Next Earnings
Q2 FY2026 — expected 2026-09-21
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | PEPG | discussed_in_filing Cybersecurity | |
| topic_mention | PEPG | discussed_in_filing Cybersecurity | |
| topic_mention | PEPG | discussed_in_filing Cybersecurity | |
| topic_mention | PEPG | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-04 | 2025-12-31 | 0001193125-26-091536 | EDGAR | 107K words |
| 2025-02-24 | 2024-12-31 | 0000950170-25-025226 | EDGAR | — |
| 2024-03-06 | 2023-12-31 | 0000950170-24-027178 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009500 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-276001 | EDGAR | 75K words |
| 2025-08-07 | 2025-06-30 | 0001193125-25-174979 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066414 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122821 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093351 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059519 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0000950170-23-060702 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039392 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-020829 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024186 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0000950170-22-017013 | EDGAR | — |
| 2022-06-16 | 2022-03-31 | 0000950170-22-011719 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-30 | 0001193125-26-131786 | EDGAR | 1K words |
| 2026-03-04 | 0001193125-26-091784 | EDGAR | — |
| 2026-03-04 | 0001193125-26-091503 | EDGAR | — |
| 2025-12-08 | 0001193125-25-310544 | EDGAR | — |
| 2025-11-12 | 0001193125-25-276019 | EDGAR | — |
| 2025-11-07 | 0001193125-25-271089 | EDGAR | — |
| 2025-10-01 | 0001193125-25-226746 | EDGAR | — |
| 2025-09-26 | 0001193125-25-218503 | EDGAR | — |
| 2025-09-24 | 0001193125-25-215435 | EDGAR | — |
| 2025-08-07 | 0001193125-25-174982 | EDGAR | — |
90 total filings indexed. 64 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001835597 |
| Ticker | PEPG |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 4bbf86ac769964897bdf6039f3a425b0edf504ec5f84b80b07989c52a4a58d63
parent: 75d79b0b6e98fc88712811e347b057ffd09a56a5ac2d08ed48fcd9e00df92d03
content hash: 37f04ef55d7be7194718bcd6325ca7f162a17c863583892e31dadd7f1f2d451e
signed: 2026-04-13T04:46:51.970Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf